Crest 3D White Toothpaste recalled for missing label and wrong formulation
Procter & Gamble is recalling Crest 3D White Fluoride Anticavity Toothpaste because some tubes lack labels and contain a different formulation than indicated. About 1,128 tubes distributed in Washington State are affected.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall for missing label and formulation mismatch with no reported illnesses. Per the severity rubric, FDA Class III recalls are typically scored 1-2, and minor labeling errors without reported harm warrant a Moderate (2) score.
Plain-English summary
Procter & Gamble is recalling Crest 3D White Fluoride Anticavity Toothpaste, Advanced Triple Whitening, 0.243% sodium fluoride (Net Wt. 5.6 oz / 158 g) distributed in Washington State. Approximately 1,128 tubes are affected by this recall.
Some tubes in this distribution were missing their label and contained a different formulation than indicated. The affected product includes both individual cartons (UPC 0 37000 598534) and 5-count bundles (UPC 037000171867) bearing lot codes 13191707B4 or 13511707Y1, both expiring October 31, 2023.
The recalled product
- Product
- Crest 3D White Fluoride Anticavity Toothpaste, Advanced Triple Whitening, 0.243% sodium fluoride, Net Wt. 5.6 oz (158 g) a) Individual carton, UPC 0 37000 598534; b) 5-count Bundle, UPC 037000171867, Distributed. By Procter & Gamble, Cincinnati, OH 45202.
- Manufacturer
- The Procter & Gamble Company
- Category
- Drug — Toothpaste
- Affected units
- 1,128
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot: a) 13191707B4
- Exp. 10/31/2023
- b)13511707Y1
- Exp. 10/31/2023.
Distribution
Distributed in 1 state:
Related recalls
Same manufacturer · The Procter & Gamble Company
See all →- ModeratePsyllium Fiber Capsules Recalled Due to Illegible Labeling
FDA (Food) · 2024-02-28
- HighSecret anti-perspirant spray recalled for potential benzene contamination
FDA (Drugs) · 2024-01-24
- SevereOld Spice Anti-Perspirant Spray Recalled Due to Benzene Contamination
FDA (Drugs) · 2024-01-24
- HighSecret OUTLAST Dry Spray Antiperspirant Recalled for Benzene Contamination
FDA (Drugs) · 2024-01-24
- SevereOld Spice Sweat Defense Spray Recalled for Benzene Contamination Nationwide
FDA (Drugs) · 2024-01-24
Same hazard · missing label
See all →- LowLevocarnitine Injection USP Missing Label Recall
FDA (Drugs) · 2026-05-06
- HighGreenpower Recalls School Buses Due to Missing Mirror Warning Label
NHTSA · 2026-04-06
- LowCT pendant upgrades recalled for missing a safe hand position label
FDA (Devices) · 2026-01-21
- LowCT pendant replacement kits recalled for missing a safe hand position label
FDA (Devices) · 2026-01-21
- LowMammography systems recalled over a missing or incorrect X-ray warning label
FDA (Devices) · 2025-12-17
Similar recalls
- ModerateColgate Anticavity Fluoride Toothpaste recalled for improper storage conditions
FDA (Drugs) · 2022-09-07
- Low3M ESPE Clinpro 5000 Toothpaste Recalled for Missing Lot and Expiration Dates
FDA (Drugs) · 2015-01-28
- ModerateColgate Anticavity Fluoride Toothpaste Recalled Due to Improper Storage Conditions
FDA (Drugs) · 2022-09-07
- ModerateCrest Pro-Health Oral Rinse Recalled for Cross-Contamination
FDA (Drugs) · 2013-02-27
- ModeratePritam International Recalls evo Fluoride Toothpaste for CGMP Deviations
FDA (Drugs) · 2026-10-28
- ModerateMaximum Security Anticavity Gel Toothpaste recalled for CGMP deviations
FDA (Drugs) · 2025-05-28